ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 571,57
0,91%
Dow Jones
38 798,60
0,54%
DAX
18 068,21
0,26%
Brent Oil
83,575
1,77%
Bitcoin
66 987,62
0,52%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Adicet Bio Inc (ACET)

  7. Adicet Bio Inc (ACET) Actualités

ACET

Adicet Bio (ACET)

Adicet Bio Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ACET
DateHeureSourceTitreSymboleSociété
07/06/202422h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
07/06/202422h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
05/06/202413h00Business WireAdicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus NephritisNASDAQ:ACETAdicet Bio Inc
31/05/202423h41Business WireAdicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
29/05/202413h00Business WireAdicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare ConferenceNASDAQ:ACETAdicet Bio Inc
14/05/202422h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACETAdicet Bio Inc
14/05/202422h01Business WireAdicet Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:ACETAdicet Bio Inc
14/05/202416h00Business WireAdicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid CongressNASDAQ:ACETAdicet Bio Inc
07/05/202413h00Business WireAdicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences ConferenceNASDAQ:ACETAdicet Bio Inc
30/04/202423h10Business WireAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
22/04/202422h30Business WireAdicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual MeetingNASDAQ:ACETAdicet Bio Inc
08/04/202413h00Business WireAdicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual ConferenceNASDAQ:ACETAdicet Bio Inc
19/03/202421h10Business WireAdicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:ACETAdicet Bio Inc
11/03/202412h00Business WireAdicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual ConferenceNASDAQ:ACETAdicet Bio Inc
05/02/202422h01Business WireAdicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:ACETAdicet Bio Inc
02/02/202417h49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACETAdicet Bio Inc
25/01/202422h01Business WireAdicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional SharesNASDAQ:ACETAdicet Bio Inc
24/01/202422h32Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACETAdicet Bio Inc
23/01/202405h43Business WireAdicet Bio, Inc. Announces Pricing of Public OfferingNASDAQ:ACETAdicet Bio Inc
22/01/202422h28Business WireAdicet Bio, Inc. Announces Proposed Public OfferingNASDAQ:ACETAdicet Bio Inc
19/01/202422h05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACETAdicet Bio Inc
04/01/202413h00Business WireAdicet Provides Corporate Update and Highlights Strategic Priorities for 2024NASDAQ:ACETAdicet Bio Inc
03/01/202422h01Business WireAdicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate OutlookNASDAQ:ACETAdicet Bio Inc
10/12/202318h00Business WireAdicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual MeetingNASDAQ:ACETAdicet Bio Inc
08/11/202322h10Business WireAdicet Reports Third Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:ACETAdicet Bio Inc
07/11/202313h00Business WireAdicet Bio to Present at the 2023 Jefferies London Healthcare ConferenceNASDAQ:ACETAdicet Bio Inc
02/11/202314h00Business WireAdicet Bio Announces Poster Presentation Highlighting ADI-001 Data at the 65th American Society of Hematology (ASH) Annual MeetingNASDAQ:ACETAdicet Bio Inc
04/10/202318h00Business WireAdicet Bio Announces Poster Presentation at the Upcoming 2023 Molecular Targets and Cancer Therapeutics ConferenceNASDAQ:ACETAdicet Bio Inc
27/09/202315h00Business WireAdicet Bio to Present Three Scientific Posters Highlighting its Allogeneic Gamma Delta T Cell Platform and Programs at the Society for Immunotherapy of Cancer (SITC) 38th Annual MeetingNASDAQ:ACETAdicet Bio Inc
09/08/202322h27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ACETAdicet Bio Inc
 Showing the most relevant articles for your search:NASDAQ:ACET

Dernières Valeurs Consultées

EU
RI
Pernod Ricard
FTSE
UKX
FTSE 100
EU
MC
Lvmh Moet Hennessy Louis...
SPI
SP500
S&P 500
EU
ORA
Orange
EU
ACA
Credit Agricole
EU
AF
Air FranceKLM
EU
BNP
BNP Paribas
EU
DG
Vinci
NASDAQ
GOOGL
Alphabet
NYSE
DIS
Walt Disney
EU
BN
Danone
COIN
ETHUSD
Ethereum
EU
VK
Vallourec
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés